VANDERBILT UNIVERSITY MEDICAL CENTER

GLP-1, a hormone released after meals, plays a crucial role in energy homeostasis and feeding behavior, with significant implications for obesity and diabetes treatment. It modulates neural circuits, influencing behavior beyond its peripheral actions. GLP-1's diverse functions, from enhancing insulin secretion to regulating appetite and reward behaviors, highlight its complex signaling system. Recent research underscores GLP-1's potential in therapeutic applications, emphasizing its role in metabolic regulation and its impact on central nervous system functions.

The study forecasts a growing shortfall of neurologists in the U.S., from 16,366 in 2012 to 18,060 by 2025, against a demand increase from 18,180 to 21,440. Factors include aging population, health care reform, and increased prevalence of neurologic conditions, leading to longer wait times and reduced access, especially for Medicaid patients.